|
1
|
Dragosics B, Bauer P and Radaszkiewicz T:
Primary gastrointestinal non-Hodgkin’s lymphomas. A retrospective
clinicopathologic study of 150 cases. Cancer. 55:1060–1073. 1985.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Radaszkiewicz T, Dragosics B and Bauer P:
Gastrointestinal malignant lymphomas of the mucosa-associated
lymphoid tissue: factors relevant to prognosis. Gastroenterology.
102:1628–1638. 1992.PubMed/NCBI
|
|
3
|
Paryani S, Hoppe RT, Burke JS, Sneed P,
Dawley D, Cox RS, Rosenberg SA and Kaplan HS: Extralymphatic
involvement in diffuse non-Hodgkin’s lymphoma. J Clin Oncol.
1:682–688. 1983.PubMed/NCBI
|
|
4
|
Aisenberg AC: Coherent view of
non-Hodgkin’s lymphoma. J Clin Oncol. 13:2656–2675. 1995.PubMed/NCBI
|
|
5
|
Severson RK and Davis S: Increasing
incidence of primary gastric lymphoma. Cancer. 66:1283–1287. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Koch P, Probst A, Berdel WE, Willich NA,
Reinartz G, Brockmann J, Liersch R, del Valle F, Clasen H, Hirt C,
et al: Treatment results in localized primary gastric lymphoma:
data of patients registered within the German multicenter study
(GIT NHL 02/96). J Clin Oncol. 23:7050–7059. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ferrucci PF and Zucca E: Primary gastric
lymphoma pathogenesis and treatment: what has changed over the past
10 years? Br J Haematol. 136:521–538. 2007. View Article : Google Scholar
|
|
8
|
Swerdlow SH, Campo E, Seto M, et al:
Mantle cell lymphoma. World Health Organization, . WHO
Classification of Tumours of Haematopoietic and Lymphoid Tissues.
Swerdlow SH: 4th edition. International Agency for Research on
Cancer; Lyon: pp. 229–232. 2008
|
|
9
|
Nakamura S, Matsumoto T, Iida M, Yao T and
Tsuneyoshi M: Primary gastrointestinal lymphoma in Japan: a
clinicopathologic analysis of 455 patients with special reference
to its time trends. Cancer. 97:2462–2473. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fischbach W, Schramm S and Goebeler E:
Outcome and quality of life favour a conservative treatment of
patients with primary gastric lymphoma. Z Gastroenterol.
49:430–435. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ouakaa-Kchaou A, Gargouri D, Elloumi H,
Kochlef A, Bouzid H, Kilani A, Romani M, Kharrat J and Ghorbel A:
Survival in patients with gastric lymphoma. Tunis Med. 89:752–757.
2011.(In French). PubMed/NCBI
|
|
12
|
Yoshita H and Sugiyama T: Gastric
malignant lymphoma. Nihon Rinsho. 70:1253–1262. 2012.(In Japanese).
PubMed/NCBI
|
|
13
|
Nam TK, Ahn JS, Choi YD, Jeong JU, Kim YH,
Yoon MS, Song JY, Ahn SJ and Chung WK: The role of radiotherapy in
the treatment of gastric mucosa-associated lymphoid tissue
lymphoma. Cancer Res Treat. 46:33–40. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu HT, Hsu C, Chen CL, Chiang IP, Chen
LT, Chen YC and Cheng AL: Chemotherapy alone versus surgery
followed by chemotherapy for stage I/IIE large-cell lymphoma of the
stomach. Am J Hematol. 64:175–179. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Selçukbiricik F, Tural D, Elicin O, Berk
S, Ozgüroğlu M, Bese N and Ferhanoglu B: Primary gastric lymphoma:
conservative treatment modality is not inferior to surgery for
early-stage disease. ISRN Oncol. 2012:9518162012.PubMed/NCBI
|
|
16
|
García M, Bellosillo B, Sánchez-González
B, García-Payarols F, Seoane A, Ferrer AM, Gimeno E, Barranco LE,
Torner A, Solé F, et al: Study of regulatory T-cells in patients
with gastric malt lymphoma: influence on treatment response and
outcome. PLoS One. 7:e516812012. View Article : Google Scholar
|
|
17
|
Shimada S, Gen T and Okamoto H: Malignant
gastric lymphoma with spontaneous perforation. BMJ Case Rep.
17:20132013.
|
